CC
NVCR icon

Corton Capital’s NovoCure NVCR Stock Holding History

Corton Capital’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$176K Buy
+13,617
New +$182K 0.43% 128
2025
Q1 		– Sell
-12,709
Closed -$379K – 333
2024
Q4 		$379K Sell
12,709
-1,555
-11% -$32.9K 0.22% 42
2024
Q3 		$223K Buy
14,264
+2,567
+22% +$46.5K 0.11% 325
2024
Q2 		$200K Sell
11,697
-24,762
-68% -$435K 0.11% 378
2024
Q1 		$570K Buy
36,459
+7,271
+25% +$107K 0.21% 122
2023
Q4 		$436K Buy
29,188
+14,121
+94% +$189K 0.14% 204
2023
Q3 		$243K Buy
+15,067
New +$434K 0.12% 251
2022
Q4 		– Sell
-3,782
Closed -$287K – 352
2022
Q3 		$287K Sell
3,782
-1,125
-23% -$87.8K 0.35% 114
2022
Q2 		$341K Buy
+4,907
New +$370K 0.32% 117

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Corton Capital's NVCR Position: Q3 2025 in Review

Corton Capital opened a new position in NovoCure (NVCR) in Q3 2025: 13,617 shares worth $176K. The stake represents 0.43% of the portfolio and ranks #128 among its holdings. This is a return to the name: Corton Capital previously reported a position in NVCR as recently as Q4 2024.

Corton Capital first reported a position in NVCR in Q2 2022 and has held it in 9 quarters since. The position peaked at $570K in Q1 2024. 244 funds tracked by Wall St. Rank hold NVCR as of Q3 2025.

  • Corton Capital held 13,617 shares of NovoCure worth $176K as of Q3 2025.
  • NovoCure was a new Corton Capital position in Q3 2025.
  • NovoCure made up 0.43% of Corton Capital's portfolio in Q3 2025, its #128 holding.
  • Corton Capital first reported a position in NovoCure in Q2 2022 and has held it in 9 quarters since.
  • Corton Capital's NovoCure position peaked at $570K in Q1 2024.
  • 244 funds tracked by Wall St. Rank held NovoCure as of Q3 2025.

Based on Corton Capital's 13F filing for Q3 2025, filed 14 Nov 2025.